Cholesterol and Other Cardiovascular Testing

Published by: Global Industry Analysts

Published: Aug. 1, 2006 - 285 Pages

Table of Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions And Scope Of Study

Lipid Panel Test/Complete Lipid Profile

Total Cholesterol Test

HDL Cholesterol Test

Apolipoprotein B

Other Apolipoprotein Tests

II. EXECUTIVE SUMMARY

1. Industry Overview

Global Market Outlook

Cholesterol Testing to Witness No-Holds Barred Growth

Tests Conducted Worldwide

Analysis by Geographic Region

Analysis by Product Segment

Home/OTC Cholesterol Test Kits Market Set for Double-Digit Growth

Growth Drivers

Aging Population Drives Home Testing Market

Extensive Awareness Campaigns for Common People

Global In-Vitro Diagnostic Products Market: An Overview

Growth Trends

Table 1: World In-Vitro Diagnostic (IVD) Testing Market (2004): Percentage Breakdown by Value Sales for United States, Europe, Japan, Asia-Pacific, and Rest of World (includes corresponding Graph/Chart)

Established Players Dominate a Fragmented Industry

Table 2: Leading Players in the Worldwide In- VitroDiagnostics Market (2004): Percentage Breakdown by Value Sales for Roche, Abbott, J & J/Ortho, Bayer, Beckman Coulter, Dade Behring, and Others (includes corresponding Graph/Chart)

Worldwide Home IVD Products Market - An Overview

2. An Insight into Cardiovascular Diseases

The Heart of Heart Problems

Types of Cardiovascular Diseases/Disorders

Coronary Artery Disease

Hyperlipidemia - An Important Risk Factor of Heart Disease

Hypertension - The Silent Killer

Two-Pronged Approach to Counter CVD

Cardiovascular Risk Assessment

3. The Good & Bad of Cholesterol

Blood Cholesterol - The Principal Cardiac Risk Marker

Types of Cholesterol

Total Cholesterol (TC)

High Density Lipoprotein (HDL)

Low Density Lipoprotein (LDL)/Very Low Density Lipoprotein (VLDL)

Triglycerides (TRG)

Glucose (GLU)

Alanine Aminotransferase (ALT)

Outcomes of High Blood Cholesterol

Atherosclerosis

Coronary Heart Disease (CHD)

Risk Factors and Risk Levels

Risk Factors

Risk Levels

Risk Level Based on Total Cholesterol Concentration

LDL-Cholesterol Risk Levels

HDL-Cholesterol Risk Levels

Triglyceride Risk Levels

4. Cholesterol Testing & CVD Risk Assessment Techniques

Cholesterol Testing

Need for Cholesterol Testing

Candidates for Cholesterol Testing

Test Procedure

Time of Testing - Crucial for Heart Disease Patients

Types of Cholesterol Testing

Lipid Panel Test/Lipid Profile

Total Cholesterol Test

HDL Cholesterol Test

Apolipoprotein Tests

Apolipoprotein A-1 Test

Apolipoprotein B100 Test

ApoE Genotyping Test

Apolipoprotein CII

Table 3: Prices of Cholesterol Tests by Type

Other Cholesterol Markers

LDL Cholesterol Testing

LDL Cholesterol Test - The First Cholesterol Testing Method

Triglycerides/VLDL Cholesterol Testing

RLP Cholesterol

Non Instrumented Technologies

Heart Disease Diagnosis Tests

Non-Invasive Tests

Invasive Tests

Other CVD Markers

Creatine Kinase MB

Troponin T and Troponin I

Myoglobin

P-selectin Profile

C-reactive Protein

Endothelial Dysfunction

Homocysteine

Plasminogen Activator Inhibitor-1

s-100 Protein

Thrombus Precursor Protein

Other Cardiac Markers

5. Point-of-Care & Home Cholesterol Testing - A Budding Market

Point of Care (POC) Medical Diagnostics

Table 4: World Home Point-of-Care (POC) Testing ProductsMarket (2004): Percentage Breakdown of Value Sales by Region - United States, Europe, Japan, and Rest of World (includes corresponding Graph/Chart)

POC Cardiac Testing

Table 5: Leading Players in the Worldwide POC Cardiac Testing Market (2004): Percentage Breakdown of Value Sales for Biosite, Dade Behring, Spectral Diagnostics, Roche, and Others (includes corresponding Graph/Chart)

Development of Home Cholesterol Testing Kits

Table 6: Cholesterol and Other Cardiovascular Test Kits Offered by Leading Companies

6. Cholesterol Control & Treatment Modalities

Prevention is Better than Cure

Dietary Therapy

Healthy Diet

Exercises

Drug Therapy

Classification of Cholesterol Lowering Drugs

Bile Acid Sequestrants

Nicotinic Acid

HMG CoA Reductase Inhibitors (Statins)

Other Drugs (Fibric Acids and Probucol)

New and Effective Drugs Being Developed

Side Effects of Cholesterol Lowering Drugs

Gemfibrozil

HMG-CoA Reductase Inhibitors

All cholesterol reducing drugs

Testing After Commencing Drug Therapy

7. An Overview of the Cardiovascular Drugs Market

A Glance at Cardiovascular Drugs Market

Leading Players

Table 7: Leading Players in the Worldwide Cardiovascular Drugs Market (2003 & 2004) - Percentage Breakdown of Value Sales for Pfizer, Merck, Bristol-Myers Squibb, Novartis, AstraZeneca/Takeda, and Others (includes corresponding Graph/Chart)

Cholesterol-Lowering Drugs Market

Leading Players

Table 8: Leading Brands in the Worldwide Cholesterol Reducing Drugs Market (2004): Percentage Breakdown of Value Sales for Lipitor (Pfizer Inc.), Zocor (Merck Inc.), Pravachol (Bristol-MyersSquibb Co.) and Others (includes corresponding Graph/Chart)

8. Product Launches/Developments

Dade Behring Unveils CardioPhase(R) hsCRP Test

PTS to Distribute First Ever Direct LDL Cholesterol Test

Liposcience Reinstates Blood Cholesterol Test

Akers Launches TrII-Cholesterol Test

Dade Behring Unveils Homocysteine Test on BN(TM) Systems

Axis-Shield Introduces BNP Assay for IMx® system of Abbott

Roche Unveils Cardiac pro-BNP Test

Accutech Introduces a new Diagnostic Test called CholesTrak for Women

Martek Devises a new Technique to Discrete DHA Residue From Triglycerides

Quantimetrix Unveils a new Diagnostic Test for Determining the Cholesterol Levels

AccuTech Launches Cholesterol Reduction System Kit

Cholestech Introduces ALT

Matsushita Develops Compact Cholesterol Sensor

9. Recent Industry Activity

Nanogen Acquires Spectral’s Cardiac Test Division

Instant Technologies Takes Over Accu-Stat Diagnostics

Source Scientific and Atherotech Collaborate for VAP Test Devices

Abbott Receives Non-exclusive Sublicense for Diagnostic Use of PIGF

Cholestech to Supply LDX® System to Mexican Ministry of Communications & Tranportation

PTS Enters into a Distribution Agreement with Medical Home Products

Olympus’ AU3000i to Expand Market for Bayer’s BNP Assay

PTS to Provide Test Strips to Lifestream Technologies for New Cholesterol/HDL Test

Skylight Biotech to Start Cholesterol Testing Center for Animals

FDA Grants CLIA Waiver for Biosite’s Triage(R) BNP Test

Response Biomedical Wins Nonexclusive License Rights for NT -proBNP and Troponin T

Medicure Gains Licensing Rights of Cholesterol- Lowering Technology

Atherotech Collaborates with Resverlogix Corp

IMI Enters into an Agreement with McNeil

Nymox Pharmaceutical Receives Patent for Saliva Cholesterol Test

LabCorp Ties Up with Atherotech to Offer VAP Cholesterol Test

ABAXIS Bags FDA Approval for Three Assays

Cholestech Obtains Approval to Market its Cholestech GDX™ System in Canada

Cholestech Sells WellCheck Subsidiary to ImpactHealth

IMI and McNeil Inks Agreement

Quaker Oats Joins Hands with Biosafe to Promote Cholesterol Testing

Agreement Between Cholestech and Bayer

Cholestech Concludes Two Agreements with Sankyo Pharma

Johnson & Johnson Acquires Heartport

Distribution Agreement Between Cholestech and Moore Medical

Cholestech Signs US$1 Million Contract with GMR

Atherotech Strikes a Deal with Healthsouth

Incyte Genomics Forms Alliance with 2 Netherlands Institutes

European Patent for Cholestech

RiceX Awards Rights to NutraStar

BioMec Forms New Subsidiary

Cholestech Buys Health Net

Lifestream Obtains Marketing Approval for its Home Cholesterol Testing Device

Polymer Receives FDA Approval to Market its HDL- Cholesterol Test Strips

Shield and Axis Merge to form Axis-Shield

Baxter Spins Off Cardiovascular Division

10. Focus on Select Global Players

AccuTech, LLC (US)

Axis-Shield Plc (UK)

Biosite Inc. (US)

Cholestech Corporation (US)

Dade Behring, Inc. (US)

Home Access Health

Lifestream Technologies, Inc. (US)

Roche Diagnostics (Switzerland)

11. Global Market Perspective

Table 9: World Recent Past, Current & Future Market Analysis for Cholesterol & Other Cardiovascular Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 10: World 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)

Table 11: World Recent Past, Current & Future Market Analysis for Lipid Panel Test/Complete Lipid Profile Test by Geographic Region -United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 12: World 10-Year Perspective for Lipid Panel Test/Complete Lipid Profile Test by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)

Table 13: World Recent Past, Current & Future Market Analysis for Total Cholesterol Testing by Geographic Region -United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 14: World 10-Year Perspective for Total Cholesterol Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)

Table 15: World Recent Past, Current & Future Market Analysis for HDL Cholesterol Testing by Geographic Region -United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 16: World 10-Year Perspective for HDL Cholesterol Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)

Table 17: World Recent Past, Current & Future Market Analysis for Apolipoprotein B Tests by Geographic Region -United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 18: World 10-Year Perspective for Apolipoprotein B Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)

Table 19: World Recent Past, Current & Future Market Analysis for Other Apolipoprotein Tests by Geographic Region -United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 20: World 10-Year Perspective for Other Apolipoprotein Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A.Market Analysis

Market Outlook

Commanding A Third of the World’s Cholesterol Testing Market

Cardiovascular Market: Startling Statistics

Table 21: Prevalence of Cardiovascular Disease (CVD) in the US: Population by Disease Type (in 000s) (includes corresponding Graph/Chart)

Cholesterol Testing - NCEP Recommendations Spurs Potential

Trends and Issues

POC Lipid Profiling Flourishes under New Guidelines

Need for Immediate and Accurate Heart Attack Diagnosis

Awareness Brings Change

Cardiovascular In Vitro Diagnostics: An Overview

Point-of-Care Testing Market - An Overview

Technological Developments Steer the Home Health Care Market

Home Diagnostic Products Market: An Overview

Home Cholesterol Testing Market - An Overview

Table 22: US Recent Past, Current & Future Analysisfor Home/OTC Cholesterol Test Kits: Annual Sales Figures in US$ Million for Years 2000 through2010 (includes corresponding Graph/Chart)

Key Players

AccuTech, LLC

Biosite Inc.

Cholestech Corporation

Dade Behring, Inc.

Home Access Health

Lifestream Technologies, Inc.

Product Developments: Historic

Product Launches

Product Launches: Historic

Strategic Developments

Strategic Developments: Historic

B.Market Analytics

Table 23: US Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 24: US 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

2. Canada

A.Market Analysis

Market Outlook

Strategic Developments

B.Market Analytics

Table 25: Canadian Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 26: Canadian 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

3. Japan

A.Market Analysis

Market Outlook

Leading the Volume Growth

Home/OTC Cholesterol Testing Market

Table 27: Japanese Recent Past, Current & Future Analysis for Home/OTC Cholesterol Test Kits Market: Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Product Launches

Strategic Corporate Development

B.Market Analytics

Table 28: Japanese Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 29: Japanese 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4. Europe

A.Market Analysis

Market Outlook

Germany Leads in Size and Growth

Strategic Corporate Developments

Point of Care Diagnostics Market Overview

Table 30: European Home Point-of-Care (POC) Diagnostics Market (2004): Annual Sales Estimates in US$ Million by Country/Region - Germany, France, Italy, Spain, United Kingdom, and Rest of Europe lncludes corresponding Graph/Chart)

Home/OTC Cholesterol Testing Market in Western Europe

Table 31: Western Europe Market for Home/OTC Cholesterol Test Kits- Recent Past, Current & Future Analysis: Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

B.Market Analytics

Table 32: European Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 33: European 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Geographic Region - Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

Table 34: European Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 35: European 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4a. France

A.Market Analysis

Market Outlook

Cardiovascular Diagnostics Equipment Market - An Overview

Functional Analysis Equipment Market - An Overview

Factors Influencing Demand for Functional Analysis Equipment

B.Market Analytics

Table 36: French Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 37: French 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4b. Germany

A.Market Analysis

Market Outlook

Strategic Corporate Development

B.Market Analytics

Table 38: German Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment -Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 39: German 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4c. Italy

A.Market Analysis

Market Outlook

B.Market Analytics

Table 40: Italian Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment -Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 41: Italian 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4d. United Kingdom

A.Market Analysis

Market Outlook

Axis-Shield Plc - A key Player

Product Launches

B.Market Analytics

Table 42: UK Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment -Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 43: UK 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4e. Spain

A.Market Analysis

Market Outlook

B.Market Analytics

Table 44: Spanish Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment -Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 45: Spanish 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4f. Russia

A.Market Analysis

Market Outlook

B.Market Analytics

Table 46: Russian Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 47: Russian 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

4g. Rest of Europe

A.Market Analysis

Market Outlook

Austria - Healthy Outlook

Health Care System in Poland - An Overview

Medical Equipment Market Overview

Production of Medical Equipment

Roche Diagnostics - A Key Player

Product Launches - Historic

Product Launch

Strategic Corporate Development

B.Market Analytics

Table 48: Rest of Europe Market for Cholesterol & Other Cardiovascular Testing - Recent Past, Current & Future Analysis by Product Segment for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 49: Rest of Europe 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

5. Asia-Pacific

A.Market Analysis

Market Outlook

Chinese Diagnostic Equipment Market

Underdeveloped Health Care System

Dominance of US Companies

Opportunities Abound

Cardiovascular Equipment/Devices Market in Hong Kong

Categorization of Health Care Services

Imports Scenario

B.Market Analytics

Table 50: Asia-Pacific Market for Cholesterol & Other Cardiovascular Testing - Recent Past, Current & Future Analysis by Product Segment for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 51: Asia-Pacific 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

6. Latin America

A.Market Analysis

B.Market Analytics

Table 52: Latin American Market for Cholesterol & Other Cardiovascular Testing - Recent Past, Current & Future Analysis by Product Segment for Lipid Panel Test/CompleteLipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 53: Latin American 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

7. Rest of World

A.Market Analysis

Market Outlook

B.Market Analytics

Table 54: Rest of World Market for Cholesterol & Other Cardiovascular Testing - Recent Past, Current & Future Analysis by Product Segment for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 55: Rest of World 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

IV. COMPETITION

1. Abbott Diagnostics Division of Abbott Laboratories (USA)

2. Accu-Stat Diagnostics (USA)

3. Accutech LLC (USA)

4. Akers Biosciences, Inc. (USA)

5. Alfa Wassermann SpA (Italy)

Alfa Wassermann, Inc. (USA)

6. Analox Instruments Ltd. (UK)

Analox Instruments USA, Inc. (USA)

7. Apex Biotechnology Corporation (Taiwan)

8. Atherotech, Inc. (USA)

9. Axis-Shield PLC (UK)

Table 56: Annual Sales Analysis: 2004-2005 (In £ million)

Table 57: Annual Sales Analysis by Segment: 2004-2005 (In £ million)

10. Bio-Rad Laboratories, Inc. (USA)

Table 58: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)

Table 59: First Quarter Sales Analysis by Segment: 2005-2006 (Q1) (In US$ million)

Table 60: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 61: Quarterly Sales Analysis: 2004-2005 (In US$ million)

Table 62: Annual Sales Analysis by Product Segment: 2004-2005 (In US$ million)

Table 63: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

11. Biosite, Inc. (USA)

Table 64: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)

Table 65: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 66: Quarterly Sales Analysis: 2004-2005 (In US$ million)

12. Capricorn Products, Inc. (USA)

13. Chematics, Inc. (USA)

14. Chemicon International, Inc. (USA)

15. Cholestech Corporation (USA)

Table 67: First Quarter Sales Analysis: 2006-2007 (Q1) (In US$ million)

Table 68: Annual Sales Analysis: 2004-2006 (In US$ million)

16. Cliniqa Corporation (USA)

17. Dade Behring, Inc. (USA)

Table 69: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 70: Half Yearly Sales Analysis by Segment: 2005- 2006 (H1) (In US$ million)

Table 71: Half Yearly Sales Analysis by Geographical Region: 2005-2006 (H1) (In US$ million)

Table 72: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 73: Quarterly Sales Analysis: 2004-2005 (In US$ million)

Table 74: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 75: Annual Sales Analysis By Geographical Region: 2004-2005 (In US$ million)

18. Denka Seiken Co., Ltd. (Japan)

19. Diagnostic Chemicals Limited (Canada)

20. Equal Diagnostics (USA)

21. Exocell, Inc. (USA)

22. Genzyme Corporation (USA)

Table 76: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ billion)

Table 77: Annual Sales Analysis: 2004-2005 (In US$ billion)

Table 78: Quarterly Sales Analysis: 2004-2005 (In US$ billion)

Table 79: Annual Sales Analysis by Segment: 2004-2005 (In US$ billion)

Table 80: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion)

23. Helena Laboratories, Inc. (USA)

24. Hemagen Diagnostics, Inc. (USA)

Table 81: Half-Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 82: Half-Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million)

Table 83: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 84: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

25. Home Access Health Corporation (USA)

26. Invitrogen Corporation (USA)

Table 85: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 86: Half Yearly Sales Analysis by Quarter: 2005- 2006 (H1) (In US$ million)

Table 87: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 88: Quarterly Sales Analysis: 2004-2005 (In US$ million)

Table 89: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

27. Johnson & Johnson (USA)

Table 90: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ billion)

Table 91: First Quarter Sales Analysis by Segment: 2005-2006 (Q1) (In US$ billion)

Table 92: First Quarter Sales Analysis by Geographic Region: 2005-2006 (Q1) (In US$ billion)

Ortho-Clinical Diagnostics (USA)

28. Kamiya Biomedical Company (USA)

29. Lifestream Technologies, Inc. (USA)

30. Liposcience, Inc. (USA)

31. Medical Home Products, Inc. (USA)

32. Nanogen, Inc. (USA)

Table 93: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)

Table 94: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 95: Quarterly Sales Analysis: 2004-2005 (In US$ million)

33. Olympus Europa GmbhH (Germany)

34. Polymer Technology Systems, Inc. (USA)

35. Quantimetrix Corporation (USA)

36. Response Biomedical Corporation (Canada)

Table 96: Annual Sales Analysis: 2004-2005 (In Can$ million)

Table 97: Quarterly Sales Analysis: 2004-2005 (In Can$ million)

37. Roche Diagnostics (Schweiz) AG (Switzerland)

Roche Diagnostics Corporation (USA)

Roche Diagnostics India Pvt., Ltd. (India)

38. Siemens Medical Solutions (USA)

39. Skylight Biotech, Inc. (Japan)

40. Source Scientific, LLC (USA)

41. Terumo Corporation (Japan)

Table 98: Annual Sales Analysis: 2004-2005 (In ¥ million)

Table 99: Annual Sales Analysis by Segment: 2004-2005 (In ¥ million)

Terumo Medical Corporation (USA)

Terumo Cardiovascular Systems Corporation (USA)

42. The Binding Site Ltd. (UK)

43. Wako Chemicals USA, Inc. (USA)

Abstract

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.